Printer Friendly

PAUL G. THOMAS - LIFECELL CORPORATION (LIFC).

(HAT601) PAUL G. THOMAS, CEO of LIFECELL CORPORATION (LIFC), describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. LIFECELL CORPORATION (LIFC) is in the BIOTECHNOLOGY industry. Published date 11/01/99. Complete text approximately 3000 words. Document # HAT601. CEO INTERVIEWS, The Wall Street Transcript, 100 Wall Street, NY 10005. Voice (212) 952 7400. Fax: (212) 668-9842. E-mail: transcript@twst.com.

Copyright 1999 Wall Street Transcript Corporation
COPYRIGHT 1999 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:PAUL G. THOMAS - LIFECELL CORPORATION (LIFC).
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Nov 1, 1999
Words:100
Previous Article:STANLEY T. CROOKE - ISIS PHARMACEUTICALS (ISIP).
Next Article:L. MICHAEL CUTRER - NORTH AMERICA SCIENTIFIC INC (NASI).
Topics:


Related Articles
LIFECELL REPORTS 1999 PRODUCT SALES INCREASE 64% OVER 1998.
Soft-tissue replacement product.
Aztec announces new NJ headquarters.
LifeCell, LifeNet and Arthrex team up to deliver acceluar allografts for sports medicine.
CEO INTERVIEW: PAUL THOMAS - LIFECELL CORPORATION (LIFC).
LifeCell posts double-digit orthopedic growth.
LifeCell product revenues rise 27% in Q1.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters